375 related articles for article (PubMed ID: 32600941)
1. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
[TBL] [Abstract][Full Text] [Related]
3. Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors.
Veccia A; Falagario U; Martini A; Marchioni M; Antonelli A; Simeone C; Cormio L; Capitanio U; Mir MC; Derweesh I; Van Poppel H; Porpiglia F; Autorino R
Eur Urol Focus; 2021 May; 7(3):574-581. PubMed ID: 32571744
[TBL] [Abstract][Full Text] [Related]
4. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
5. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
[TBL] [Abstract][Full Text] [Related]
6. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
7. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
[TBL] [Abstract][Full Text] [Related]
8. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
[TBL] [Abstract][Full Text] [Related]
9. Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
Boulenger de Hauteclocque A; Ferrer L; Ambrosetti D; Ricard S; Bigot P; Bensalah K; Henon F; Doumerc N; Méjean A; Verkarre V; Dariane C; Larré S; Champy C; de La Taille A; Bruyère F; Rouprêt M; Paparel P; Droupy S; Fontenil A; Patard JJ; Durand X; Waeckel T; Lang H; Lebâcle C; Guy L; Pignot G; Durand M; Long JA; Charles T; Xylinas E; Boissier R; Yacoub M; Colin T; Bernhard JC
BJU Int; 2023 Aug; 132(2):160-169. PubMed ID: 36648124
[TBL] [Abstract][Full Text] [Related]
10. Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors.
Senguttuvan Karthikeyan V; Mallya A; Sivaraman A; Galiano M; Rozet F; Cathala N; Barret E; Mombet A; Prapotnich D; Sanchez-Salas R; Cathelineau X
Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):234-240. PubMed ID: 30857765
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
12. Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset.
Veccia A; Antonelli A; Minervini A; Mottrie A; Dell'Oglio P; Ashrafi AN; Larcher A; Eun D; Bradshaw A; Amparore D; Brassetti A; Hampton LJ; Simeone C; Mari A; Carini M; De Naeyer G; Yang K; Capitanio U; Simone G; Porpiglia F; Derweesh I; Aron M; Autorino R
Urol Oncol; 2020 Apr; 38(4):286-292. PubMed ID: 31956077
[TBL] [Abstract][Full Text] [Related]
13. Prognostic features of upstaged pT3a renal tumors with fat invasion after robot-assisted partial nephrectomy: is it time for a new subclassification?
Di Maida F; Campi R; Grosso AA; Lambertini L; Cadenar A; Giudici S; Pecoraro A; Mari A; Serni S; Minervini A;
Eur J Surg Oncol; 2023 Apr; 49(4):862-867. PubMed ID: 36528511
[TBL] [Abstract][Full Text] [Related]
14. Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study.
Tian J; Zeng X; Wan J; Gan J; Ke C; Guan W; Hu Z; Yang C
Front Oncol; 2021; 11():819098. PubMed ID: 35155208
[TBL] [Abstract][Full Text] [Related]
15. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
[TBL] [Abstract][Full Text] [Related]
16. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy.
Russell CM; Lebastchi AH; Chipollini J; Niemann A; Mehra R; Morgan TM; Miller DC; Palapattu GS; Hafez KS; Sexton WJ; Spiess PE; Weizer AZ
Urology; 2018 Jul; 117():95-100. PubMed ID: 29678662
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
19. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
20. Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group).
Cerrato C; Meagher MF; Autorino R; Simone G; Yang B; Uzzo RG; Kutikov A; Porpiglia F; Capitanio U; Montorsi F; Porter J; Beksac AT; Puri D; Nguyen M; Wang L; Hakimi K; Dhanji S; Liu F; Cerruto MA; Pandolfo SD; Minervini A; Lau C; Monish A; Eun D; Mottrie A; Mir C; Sundaram C; Antonelli A; Kaouk J; Derweesh IH
Minerva Urol Nephrol; 2023 Aug; 75(4):425-433. PubMed ID: 37530659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
